068270.KS
Price:
$170100
Market Cap:
$39.01T
Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the development and manufacturing of protein-based therapies, including treatments for oncology. Its commercial portfolio features established products such as Remsima, Truxima, and Herzuma, alongside a range of generic pharmaceuticals and diagnostic kits for COVID-19. The company maintains an extensive pipeline of antibody biosimilars currently undergoing various stages of clinical evaluation. Late-stage (Phase 3) candidates include CT-P17, aimed at rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD); CT-P16, targeting metastatic colorectal and breast cancers; CT-P43, for inflammatory condi...[Read more]
Industry
Biotechnology
IPO Date
2005-07-19
Stock Exchange
KSC
Ticker
068270.KS
According to Celltrion, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 27.81. This represents a change of -48.50% compared to the average of 54.00 of the last 4 quarters.
The mean historical PE Ratio of Celltrion, Inc. over the last ten years is 66.15. The current 27.81 PE Ratio has changed 4.10% with respect to the historical average. Over the past ten years (40 quarters), 068270.KS's PE Ratio was at its highest in in the December 2023 quarter at 7.43K. The PE Ratio was at its lowest in in the December 2025 quarter at 18.77.
Average
66.15
Median
68.33
Minimum
35.84
Maximum
96.83
Discovering the peaks and valleys of Celltrion, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.67%
Maximum Annual PE Ratio = 96.83
Minimum Annual Increase = -55.73%
Minimum Annual PE Ratio = 35.84
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 38.60 | -55.73% |
| 2024 | 87.19 | 48.66% |
| 2023 | 58.65 | 63.67% |
| 2022 | 35.84 | -20.95% |
| 2021 | 45.33 | -49.66% |
| 2020 | 90.05 | 28.64% |
| 2019 | 70.00 | -27.70% |
| 2018 | 96.83 | 45.28% |
| 2017 | 66.65 | -7.83% |
| 2016 | 72.31 | 21.39% |
The current PE Ratio of Celltrion, Inc. (068270.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
61.48
5-year avg
53.12
10-year avg
66.15
Celltrion, Inc.’s PE Ratio is greater than GeneOne Life Science, Inc. (-0.23), less than Alteogen Inc. (110.29), greater than SK bioscience Co.,Ltd. (-31.24), greater than SK Biopharmaceuticals Co., Ltd. (17.95), greater than Genexine, Inc. (-5.18), greater than D&D Pharmatech (-107.49), greater than SillaJen, Inc. (-11.42), greater than Voronoi, Inc. (-40.77), greater than OliX Pharmaceuticals,Inc (-170.99), greater than Peptron, Inc. (-145.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.23 | $48.42B | |
| 110.29 | $14.34T | |
| -31.24 | $2.57T | |
| 17.95 | $6.01T | |
| -5.18 | $106.42B | |
| -107.49 | $2.58T | |
| -11.42 | $275.71B | |
| -40.77 | $2.30T | |
| -170.99 | $2.09T | |
| -145.03 | $2.41T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celltrion, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celltrion, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Celltrion, Inc.'s PE Ratio?
How is the PE Ratio calculated for Celltrion, Inc. (068270.KS)?
What is the highest PE Ratio for Celltrion, Inc. (068270.KS)?
What is the 3-year average PE Ratio for Celltrion, Inc. (068270.KS)?
What is the 5-year average PE Ratio for Celltrion, Inc. (068270.KS)?
How does the current PE Ratio for Celltrion, Inc. (068270.KS) compare to its historical average?